Page 10 - Crispr News Today

Patent JP6692856 upheld for second time in response to invalidation challenge.

CAR T therapy safety falls into question as the FDA investigates reports of rare T cell lymphoma after treatment. This concern could be resolved with CRISPR technology.

The approval of the first Crispr-based therapy is just the beginning. Getting it to patients is the next hurdle.

The single-dose therapy involves treating and editing patient stem cells ex vivo, then reinfusing them.

Patients with severe sickle cell disease could soon be freed from vaso-occlusive crises after receiving an infusion of exa-cel, the first gene-editing therapy to use CRISPR technology.

Bluebird bio said on Thursday a large insurer had agreed to cover its newly approved sickle cell disease gene therapy, easing some investor worries about resistance from...

Humans can benefit significantly from symbiotic relationships with probiotics-;live bacteria and microorganisms that influence the gut microbiota.

InnovationRx is your weekly digest of healthcare news. Sign up!

Last week marked the historic Food and Drug Administration approval of the first CRISPR therapy. Five other Nobel-winning breakthroughs have led to recent new medicines.

Dr. Jeff Pothoff with University of Wisconsin Health explains sickle cell treatment which uses gene-editing tool CRISPR to prevent red blood cell 'sickling'